Related references
Note: Only part of the references are listed.Role of mitochondrial dysfunction in cancer progression
Chia-Chi Hsu et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Inhibition of human DNA topoisomerase IB by nonmutagenic ruthenium( II)-based compounds with antitumoral activity
Mariana S. de Camargo et al.
METALLOMICS (2016)
Cis-[RuCl(BzCN)(N-N)(P-P)WF6 complexes: Synthesis and in vitro antitumor activity (BzCN = benzonitrile; N-N=2,2 '-bipyridine; 1,10-phenanthroline; P-P=1,4-bis(diphenylphosphino) butane, 1,2-bis(diphenylphosphino)ethane, or 1,1 '-(diphenylphosphino)ferrocene)
Flavia de C. Pereira et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
Ru(II)-based complexes with N-(acyl)-N′,N′-(disubstituted)thiourea ligands: Synthesis, characterization, BSA- and DNA-binding studies of new cytotoxic agents against lung and prostate tumour cells
Rodrigo S. Correa et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2015)
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
L. Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2015)
Mitochondria are the primary target in the induction of apoptosis by chiral ruthenium(II) polypyridyl complexes in cancer cells
Jin-Quan Wang et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2014)
The DNA Damage Response Induced by Infection with Human Cytomegalovirus and Other Viruses
Xiaofei E et al.
VIRUSES-BASEL (2014)
Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex
Yu Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Anticancer activity of ruthenium(II) arene complexes bearing 1,2,3,4-tetrahydroisoquinoline amino alcohol ligands
Madichaba P. Chelopo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
DNA interaction, cytotoxicity, apoptotic activity, cell cycle arrest, reactive oxygen species and mitochondrial membrane potential assay induced by ruthenium(II) polypyridyl complexes
Yang-Yin Xie et al.
INORGANICA CHIMICA ACTA (2013)
The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium(II) asymmetric complexes
Chen Qian et al.
METALLOMICS (2013)
Ruthenium methylimidazole complexes induced apoptosis in lung cancer A549 cells through intrinsic mitochondrial pathway
Xiaoxin Yang et al.
BIOCHIMIE (2012)
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
L. Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2012)
Ruthenium complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers
Linlin Li et al.
DALTON TRANSACTIONS (2012)
Synthesis and cellular impact of diene-ruthenium(II) complexes: A new class of organoruthenium anticancer agents
Christine Kasper et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and-resistant human ovarian cancer cells
Gaetano Marverti et al.
INVESTIGATIONAL NEW DRUGS (2011)
The Ruthenium Complex cis-(Dichloro)tetraammineruthenium(III) Chloride Presents Selective Cytotoxicity Against Murine B Cell Lymphoma (A-20), Murine Ascitic Sarcoma 180 (S-180), Human Breast Adenocarcinoma (SK-BR-3), and Human T Cell Leukemia (Jurkat) Tumor Cell Lines
Elisangela de Paula Silveira-Lacerda et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2010)
The ruthenium complex cis-(dichloro)tetrammineruthenium(III) chloride induces apoptosis and damages DNA in murine sarcoma 180 cells
Aliny Pereira de Lima et al.
JOURNAL OF BIOSCIENCES (2010)
Soft Tissue Sarcoma
George D. Demetri et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2010)
Investigations of the possible pharmacological effects of organotin(II) complexes
Ashu Chaudhary et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
The comet assay: a method to measure DNA damage in individual cells
Peggy L. Olive et al.
NATURE PROTOCOLS (2006)
Characterization of cells with different mitochondrial membrane potential during apoptosis
E Lugli et al.
CYTOMETRY PART A (2005)
Cancer and cell cicle-specific and cell cicle nonspecific anticancer DNA-interactive agents: An introduction.
VL de Almeida et al.
QUIMICA NOVA (2005)
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes
YK Yan et al.
CHEMICAL COMMUNICATIONS (2005)
Control of apoptosis by p53
JS Fridman et al.
ONCOGENE (2003)
New metal complexes as potential therapeutics
CX Zhang et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2003)
Live or let die: The cell's response to p53
KH Vousden et al.
NATURE REVIEWS CANCER (2002)
Quantitation of mitochondrial alterations associated with apoptosis
M Castedo et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer
RE Aird et al.
BRITISH JOURNAL OF CANCER (2002)
Share Paper
